ZMYND11 and renal carcinoma: This can also be seen with BRAM1 expression in clinical samples, where Bram1 is expressed at lower levels (Figure 1). In cell lines, miR-196a was over-expressed in all the three renal cancer cell lines compared to HEK293 cells (Figure 3C). Based on the expression level of miR-196a in different renal cancer cells, miR-196a plasmids were overexpressed in HEK293T cells while anti-miR-196a were transfected in RCC4 cells for the subsequent experiments.